You probably know someone with non-alcoholic fatty liver disease or have heard about the condition before (even if you're not totally sure what it is). That's because fatty liver is common, affecting ...

GREENVILLE, N.C. (WITN) - There’s a new and alarming trend about alcohol-related liver disease in young adults. The Journal of the American Medicine Association found that more young people are ...

Liver damage from alcohol-associated liver disease may be possibly reversible in its early stages. In all stages, alcohol cessation is considered critical to overall outlook. Alcohol-associated liver ...

Fatty liver disease (also called steatotic liver disease) happens when too much fat builds up in your liver. It can be caused by high alcohol use or metabolic syndrome (a group of conditions like ...

Your liver silently performs hundreds of essential functions daily, from filtering toxins to supporting digestion and metabolism. Yet this resilient organ faces a formidable adversary in alcohol. The ...

Fatty liver disease is a health condition in which fat builds up in the liver. This fat buildup can cause inflammation and, in severe cases, liver damage. There are two main types of fatty liver ...

Alcoholic hepatitis is a severe liver condition caused by long-term heavy alcohol use, leading to inflammation and potential liver failure. Symptoms include jaundice, nausea, abdominal pain, fatigue, ...

Alcoholic cirrhosis is the severe, final stage of alcohol-associated liver disease, resulting from long-term heavy alcohol consumption. The disease involves permanent scarring of the liver, which ...

Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom ...

Your liver works tirelessly as your body’s natural filtration system, processing everything you consume and protecting you from harmful substances. When it comes to alcohol, however, this remarkable ...

Novo Nordisk is investigating the potential of Ozempic, Wegovy’s active ingredient and two other drug candidates as treatments for alcohol-related liver disease. The phase 2 trial will see how ...